Evidence map›Paper›PMID 37647915›Full record

ArticlePlanta medica2023

Immulina as an Immunostimulatory Supplement: Formulation and Pharmacological Studies.

Yusheng Li, Nan Ji, Minia Wang, Nirmal D Pugh, Ikhlas A Khan, Chalet Tan

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Planta medica, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.5field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. SpirulinaLife (Basel, Switzerland) · 2024
    Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Yusheng Li *Department of Pharmaceutics and Drug Delivery, University of Mississippi, University, Mississippi, USA.
Nan Ji *Department of Pharmaceutics and Drug Delivery, University of Mississippi, University, Mississippi, USA.
Minia Wang *Department of Pharmaceutics and Drug Delivery, University of Mississippi, University, Mississippi, USA.
Nirmal D PughNational Center for Natural Products Research, Research Institute of Pharmaceutical Sciences, University of Mississippi, University, Mississippi, USA.
Ikhlas A KhanNational Center for Natural Products Research, Research Institute of Pharmaceutical Sciences, University of Mississippi, University, Mississippi, USA.
Chalet TanDepartment of Pharmaceutical Sciences, University of Tennessee Health Science Center, Memphis, Tennessee, USA.ORCID 0000-0001-7489-7699
University of Mississippi · USUniversity of Tennessee Health Science Center · US

Funding

Unravelling Immune Enhancement by ImmulinaU19AT010838 · NCCIH · UNIVERSITY OF MISSISSIPPI · PI MARSHALL, GAILEN D. · 2020 to 2024
$6.1M
NCCIH NIH HHS U19 AT010838
6 · The paper itself

Abstract

Immulina is a commercially available extract of

Indexed as

NanoparticlesToll-Like Receptor 2Adjuvants, ImmunologicAnimalsMacrophagesMiceParticle SizePolysaccharides, BacterialSolubilityAdjuvants, ImmunologicImmulinaPolysaccharides, BacterialToll-Like Receptor 2

Identifiers

PMID37647915
PMCPMC10993770
OpenAlexW4386279180

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.